ADIPOQ and Insulin resistance: In a previous study, we showed that serum adiponectin levels and homeostasis model assessment for insulin resistance (HOMA-IR) values had clinical significance for predicting prognosis in HR-negative breast cancer patients, and interventions for increasing serum adiponectin levels and decreasing insulin resistance may be helpful in preventing recurrence.